My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 317

    1.

    Repaglinide/troglitazone combination therapy: improved glycemic control in type 2 diabetes.

    Raskin P, Jovanovic L, Berger S, Schwartz S, Woo V, Ratner R.

    Diabetes Care. 2000 Jul;23(7):979-83.PMID: 10895850 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes.

    Moses R, Slobodniuk R, Boyages S, Colagiuri S, Kidson W, Carter J, Donnelly T, Moffitt P, Hopkins H.

    Diabetes Care. 1999 Jan;22(1):119-24.PMID: 10333912 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Combination therapy for type 2 diabetes: repaglinide plus rosiglitazone.

    Raskin P, McGill J, Saad MF, Cappleman JM, Kaye W, Khutoryansky N, Hale PM; Repaglinide/Rosiglitazone Study Group.

    Diabet Med. 2004 Apr;21(4):329-35.PMID: 15049934 [PubMed - indexed for MEDLINE]Related articles

    4.

    Long-term effects of troglitazone: open-label extension studies in type 2 diabetic patients.

    Fonseca V, Foyt HL, Shen K, Whitcomb R.

    Diabetes Care. 2000 Mar;23(3):354-9.PMID: 10868865 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Repaglinide versus nateglinide monotherapy: a randomized, multicenter study.

    Rosenstock J, Hassman DR, Madder RD, Brazinsky SA, Farrell J, Khutoryansky N, Hale PM; Repaglinide Versus Nateglinide Comparison Study Group.

    Diabetes Care. 2004 Jun;27(6):1265-70.PMID: 15161773 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Troglitazone monotherapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled study. The Troglitazone Study Group.

    Fonseca VA, Valiquett TR, Huang SM, Ghazzi MN, Whitcomb RW.

    J Clin Endocrinol Metab. 1998 Sep;83(9):3169-76.PMID: 9745421 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Treatment of type 2 diabetes with a combination regimen of repaglinide plus pioglitazone.

    Jovanovic L, Hassman DR, Gooch B, Jain R, Greco S, Khutoryansky N, Hale PM.

    Diabetes Res Clin Pract. 2004 Feb;63(2):127-34.PMID: 14739053 [PubMed - indexed for MEDLINE]Related articles

    8.

    The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial.

    Yale JF, Valiquett TR, Ghazzi MN, Owens-Grillo JK, Whitcomb RW, Foyt HL.

    Ann Intern Med. 2001 May 1;134(9 Pt 1):737-45.PMID: 11329231 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The efficacy of repaglinide monotherapy and in combination with metformin in Indonesian type 2 diabetes mellitus patients.

    Soegondo S, Subekti I, Luthariana L.

    Acta Med Indones. 2004 Jul-Sep;36(3):142-7.PMID: 15557683 [PubMed - indexed for MEDLINE]Related articles

    10.

    Efficacy and safety of combination therapy: repaglinide plus metformin versus nateglinide plus metformin.

    Raskin P, Klaff L, McGill J, South SA, Hollander P, Khutoryansky N, Hale PM; Repaglinide vs. Nateglinide Metformin Combination Study Group.

    Diabetes Care. 2003 Jul;26(7):2063-8. Erratum in: Diabetes Care. 2003 Sep;26(9):2708. PMID: 12832314 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Troglitazone in combination with sulfonylurea restores glycemic control in patients with type 2 diabetes. The Troglitazone Study Group.

    Horton ES, Whitehouse F, Ghazzi MN, Venable TC, Whitcomb RW.

    Diabetes Care. 1998 Sep;21(9):1462-9.PMID: 9727892 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes.

    Chu NV, Kong AP, Kim DD, Armstrong D, Baxi S, Deutsch R, Caulfield M, Mudaliar SR, Reitz R, Henry RR, Reaven PD.

    Diabetes Care. 2002 Mar;25(3):542-9. Erratum in: Diabetes Care 2002 May;25(5):947. PMID: 11874944 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    A 1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes. Dutch and German Repaglinide Study Group.

    Wolffenbuttel BH, Landgraf R.

    Diabetes Care. 1999 Mar;22(3):463-7.PMID: 10097930 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Troglitazone add-on therapy to a combination of sulfonylureas plus metformin achieved and sustained effective diabetes control.

    Gavin LA, Barth J, Arnold D, Shaw R.

    Endocr Pract. 2000 Jul-Aug;6(4):305-10.PMID: 11242607 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effects of troglitazone: a new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy.

    Iwamoto Y, Kosaka K, Kuzuya T, Akanuma Y, Shigeta Y, Kaneko T.

    Diabetes Care. 1996 Feb;19(2):151-6.PMID: 8718436 [PubMed - indexed for MEDLINE]Related articles

    16.

    Flexible meal-related dosing with repaglinide facilitates glycemic control in therapy-naive type 2 diabetes.

    Moses RG, Gomis R, Frandsen KB, Schlienger JL, Dedov I.

    Diabetes Care. 2001 Jan;24(1):11-5.PMID: 11194214 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Effect of combination therapy of troglitazone and sulphonylureas in patients with Type 2 diabetes who were poorly controlled by sulphonylurea therapy alone.

    Iwamoto Y, Kosaka K, Kuzuya T, Akanuma Y, Shigeta Y, Kaneko T.

    Diabet Med. 1996 Apr;13(4):365-70.PMID: 9162613 [PubMed - indexed for MEDLINE]Related articles

    18.

    Repaglinide versus glyburide: a one-year comparison trial.

    Marbury T, Huang WC, Strange P, Lebovitz H.

    Diabetes Res Clin Pract. 1999 Mar;43(3):155-66.PMID: 10369424 [PubMed - indexed for MEDLINE]Related articles

    19.

    Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and troglitazone in type 2 diabetes.

    Strowig SM, Avilés-Santa ML, Raskin P.

    Diabetes Care. 2002 Oct;25(10):1691-8.PMID: 12351463 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.

    Horton ES, Clinkingbeard C, Gatlin M, Foley J, Mallows S, Shen S.

    Diabetes Care. 2000 Nov;23(11):1660-5.PMID: 11092289 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity